Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. In-vitro fertilization services industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Procedure trends
2.1.3. Age group trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. In-vitro Fertilization Services Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising prevalence of infertility across the globe
3.3.1.2. Various government initiatives in developed and developing nations
3.3.1.3. Rising awareness pertaining to application of IVF services
3.3.1.4. Demographical shift
3.3.2. Industry pitfalls & challenges
3.3.2.1. Poor reimbursement scenario and social barriers in developing economies
3.3.2.2. High cost of IVF procedures in developed nations
3.4. Growth potential analysis
3.4.1. By procedure
3.4.2. By age group
3.4.3. By end-use
3.5. Regulatory scenario
3.6. Porter’s analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. In-vitro Fertilization Services Market, By Product
4.1. Key segment trends
4.2. In-vitro fertilization (IVF)
4.2.1. Market size, by region, 2014 – 2025 (USD Million)
4.3. Intracytoplasmic sperm injection (ICSI)
4.3.1. Market size, by region, 2014 – 2025 (USD Million)
Chapter 5. In-vitro Fertilization Services Market, By Age Group
5.1. Key segment trends
5.2. Below 34
5.2.1. Market size, by region, 2014 – 2025 (USD Million)
5.3. 35-39
5.3.1. Market size, by region, 2014 – 2025 (USD Million)
5.4. 40-42
5.4.1. Market size, by region, 2014 – 2025 (USD Million)
5.5. 43 and Above
5.5.1. Market size, by region, 2014 – 2025 (USD Million)
Chapter 6. In-vitro Fertilization Services Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2014 – 2025 (USD Million)
6.3. Fertility Centers
6.3.1. Market size, by region, 2014 – 2025 (USD Million)
6.4. Surgical Centers
6.4.1. Market size, by region, 2014 – 2025 (USD Million)
6.5. Others
6.5.1. Market size, by region, 2014 – 2025 (USD Million)
Chapter 7. In-vitro Fertilization Services Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country, 2014 – 2025
7.2.2. Market size, by procedure, 2014 – 2025
7.2.3. Market size, by age group, 2014 – 2025
7.2.4. Market size, by end-use, 2014 – 2025
7.2.5. U.S.
7.2.5.1. Market size, by procedure, 2014 – 2025
7.2.5.2. Market size, by age group, 2014 – 2025
7.2.5.3. Market size, by end-use, 2014 – 2025
7.2.6. Canada
7.2.6.1. Market size, by procedure, 2014 – 2025
7.2.6.2. Market size, by age group, 2014 – 2025
7.2.6.3. Market size, by end-use, 2014 – 2025
7.3. Europe
7.3.1. Market size, by country, 2014 – 2025
7.3.2. Market size, by procedure, 2014 – 2025
7.3.3. Market size, by age group, 2014 – 2025
7.3.4. Market size, by end-use, 2014 – 2025
7.3.5. Germany
7.3.5.1. Market size, by procedure, 2014 – 2025
7.3.5.2. Market size, by age group, 2014 – 2025
7.3.5.3. Market size, by end-use, 2014 – 2025
7.3.6. UK
7.3.6.1. Market size, by procedure, 2014 – 2025
7.3.6.2. Market size, by age group, 2014 – 2025
7.3.6.3. Market size, by end-use, 2014 – 2025
7.3.7. France
7.3.7.1. Market size, by procedure, 2014 – 2025
7.3.7.2. Market size, by age group, 2014 – 2025
7.3.7.3. Market size, by end-use, 2014 – 2025
7.3.8. Spain
7.3.8.1. Market size, by procedure, 2014 – 2025
7.3.8.2. Market size, by age group, 2014 – 2025
7.3.8.3. Market size, by end-use, 2014 – 2025
7.3.9. Italy
7.3.9.1. Market size, by procedure, 2014 – 2025
7.3.9.2. Market size, by age group, 2014 – 2025
7.3.9.3. Market size, by end-use, 2014 – 2025
7.3.10. Russia
7.3.10.1. Market size, by procedure, 2014 – 2025
7.3.10.2. Market size, by age group, 2014 – 2025
7.3.10.3. Market size, by end-use, 2014 – 2025
7.3.11. Poland
7.3.11.1. Market size, by procedure, 2014 – 2025
7.3.11.2. Market size, by age group, 2014 – 2025
7.3.11.3. Market size, by end-use, 2014 – 2025
7.3.12. Greece
7.3.12.1. Market size, by procedure, 2014 – 2025
7.3.12.2. Market size, by age group, 2014 – 2025
7.3.12.3. Market size, by end-use, 2014 – 2025
7.4. Asia Pacific
7.4.1. Market size, by country, 2014 – 2025
7.4.2. Market size, by procedure, 2014 – 2025
7.4.3. Market size, by age group, 2014 – 2025
7.4.4. Market size, by end-use, 2014 – 2025
7.4.5. Japan
7.4.5.1. Market size, by procedure, 2014 – 2025
7.4.5.2. Market size, by age group, 2014 – 2025
7.4.5.3. Market size, by end-use, 2014 – 2025
7.4.6. China
7.4.6.1. Market size, by procedure, 2014 – 2025
7.4.6.2. Market size, by age group, 2014 – 2025
7.4.6.3. Market size, by end-use, 2014 – 2025
7.4.7. India
7.4.7.1. Market size, by procedure, 2014 – 2025
7.4.7.2. Market size, by age group, 2014 – 2025
7.4.7.3. Market size, by end-use, 2014 – 2025
7.4.8. Australia
7.4.8.1. Market size, by procedure, 2014 – 2025
7.4.8.2. Market size, by age group, 2014 – 2025
7.4.8.3. Market size, by end-use, 2014 – 2025
7.4.9. South Korea
7.4.9.1. Market size, by procedure, 2014 – 2025
7.4.9.2. Market size, by age group, 2014 – 2025
7.4.9.3. Market size, by end-use, 2014 – 2025
7.5. Latin America
7.5.1. Market size, by country, 2014 – 2025
7.5.2. Market size, by procedure, 2014 – 2025
7.5.3. Market size, by age group, 2014 – 2025
7.5.4. Market size, by end-use, 2014 – 2025
7.5.5. Argentina
7.5.5.1. Market size, by procedure, 2014 – 2025
7.5.5.2. Market size, by age group, 2014 – 2025
7.5.5.3. Market size, by end-use, 2014 – 2025
7.5.6. Brazil
7.5.6.1. Market size, by procedure, 2014 – 2025
7.5.6.2. Market size, by age group, 2014 – 2025
7.5.6.3. Market size, by end-use, 2014 – 2025
7.5.7. Mexico
7.5.7.1. Market size, by procedure, 2014 – 2025
7.5.7.2. Market size, by age group, 2014 – 2025
7.5.7.3. Market size, by end-use, 2014 – 2025
7.6. MEA
7.6.1. Market size, by country, 2014 – 2025
7.6.2. Market size, by procedure, 2014 – 2025
7.6.3. Market size, by age group, 2014 – 2025
7.6.4. Market size, by end-use, 2014 – 2025
7.6.5. Israel
7.6.5.1. Market size, by procedure, 2014 – 2025
7.6.5.2. Market size, by age group, 2014 – 2025
7.6.5.3. Market size, by end-use, 2014 – 2025
7.6.6. Egypt
7.6.6.1. Market size, by procedure, 2014 – 2025
7.6.6.2. Market size, by age group, 2014 – 2025
7.6.6.3. Market size, by end-use, 2014 – 2025
Chapter 8. Company Profiles
8.1. IVIRMA Global
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Ovation Fertility
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. AVA Clinic Scanfert
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Bangkok IVF Center
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. Bourn Hall Fertility Clinic
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Cardone & Associates Reproductive Medicine & Infertility, LLC
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Nova IVI Fertility
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Max HealthCare Pvt. Ltd.
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Nuffield Health
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Morpheus Life Sciences Pvt. Ltd.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
